Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1)The percentage is calculated based upon an aggregate of 31,826,549 Ordinary Shares outstanding as of December 31, 2024, which is based on the information provided by the Issuer.


SCHEDULE 13G



 
Lin Bioscience International Ltd.
 
Signature:Yu-Hsin Lin
Name/Title:Yu-Hsin Lin/Director
Date:01/21/2025